Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Italy gives approval to trial osteoporosis drug for Covid-19 treatment

pharmaceutical-technologyOctober 29, 2020

Tag: COVID-19 , Italy , AIFA , raloxifene , Osteoporosis drug

PharmaSources Customer Service